With reference to point no. 2 of Annexure 1 of letter no. NLL/CS/2024-438 dated November 22, 2024, vide which the Company had informed pending Litigation(s) as required under Regulation 30 of the LODR Regulations. Pursuant to captioned regulations, Nectar Lifescience has informed that it enclosed necessary disclosures in prescribed format for details/ updation of Litigation and/ or orders passed by any regulatory authority or judicial body as per Annexure-A. The relevant extract of letter no. NLL/CS/2024-438 dated November 22, 2024, is attached as an Annexure B.
The above information is a part of company’s filings submitted to BSE.
